Make It or Take It: Fatty Acid Metabolism of Apicomplexan Parasites
- 1 October 2007
- journal article
- review article
- Published by American Society for Microbiology in Eukaryotic Cell
- Vol. 6 (10) , 1727-1735
- https://doi.org/10.1128/ec.00255-07
Abstract
Lipids are essential and highly abundant components of all organisms. They serve as the main building blocks of the mem- branes that surround and compartmentalize cells, as a store for energy and reduction power, and in posttranslational modifi- cations that regulate the localization and function of a large number of proteins. Lipids have also emerged as important pathogenesis factors in a variety of infectious diseases. The ability to synthesize or salvage simple components like fatty acids and isoprenoids and assemble them into more complex molecules is critical for the growth and development of the pathogen and required for its ability to colonize the host and to cause disease. Here we will focus on the fatty acid metabolism of apicomplexans, a group of unicellular eukaryotes that have adapted to an obligate intracellular life style. Infections with apicomplexan parasites are the cause of several important hu- man diseases (malaria, toxoplasmosis, and cryptosporidiosis) affecting literally millions of people around the globe. Control efforts for these diseases face an uphill battle, as effective vaccines are lacking for any of these parasites and drug treat- ment is not fully effective (cryptosporidiosis), limited to the acute stage (toxoplasmosis), or constantly threatened by emerging drug resistance (malaria). The completion of full genome sequencing efforts for a considerable number of api- complexans has reinvigorated the search for targets of novel therapeutics. Lipid and fatty acid metabolism has emerged at the heart of several intensively studied areas of apicomplexan biology, including parasite adaptation to different hosts, host- parasite interaction at the cellular level, and the identification of divergent pathogen-specific targets for antiparasitic drug therapy. Here we will provide an overview of the surprisingly diverse mechanisms of fatty acid synthesis (FAS) and uptake used by the members of this important group of pathogens. MAKE IT I: THE APICOPLAST TYPE II FATTY ACID SYNTHESIS PATHWAYKeywords
This publication has 86 references indexed in Scilit:
- Discovery of novel inhibitors targeting enoyl–acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screeningBiochemical and Biophysical Research Communications, 2007
- Studies ofToxoplasma gondiiandPlasmodium falciparumenoyl acyl carrier protein reductase and implications for the development of antiparasitic agentsActa Crystallographica Section D-Biological Crystallography, 2007
- Scavenging of the cofactor lipoate is essential for the survival of the malaria parasite Plasmodium falciparumMolecular Microbiology, 2007
- Functional characterization of the acyl-[acyl carrier protein] ligase in the Cryptosporidium parvum giant polyketide synthasePublished by Elsevier ,2006
- Enzymes of type II fatty acid synthesis and apicoplast differentiation and division in Eimeria tenellaInternational Journal for Parasitology, 2006
- Apicoplast fatty acid synthesis is essential for organelle biogenesis and parasite survival inToxoplasma gondiiProceedings of the National Academy of Sciences, 2006
- Functional characterization of a fatty acyl-CoA-binding protein (ACBP) from the apicomplexan Cryptosporidium parvumMicrobiology, 2006
- The Biosynthesis of Polyketide Metabolites by DinoflagellatesPublished by Elsevier ,2006
- Membrane transporters in the relict plastid of malaria parasitesProceedings of the National Academy of Sciences, 2006
- Toxoplasma gondii scavenges host-derived lipoic acid despite its de novo synthesis in the apicoplastThe EMBO Journal, 2006